vs
BICYCLE THERAPEUTICS PLC（BCYC）与Dominari Holdings Inc.（DOMH）财务数据对比。点击上方公司名可切换其他公司
BICYCLE THERAPEUTICS PLC的季度营收约是Dominari Holdings Inc.的1.6倍（$48.0M vs $30.1M），BICYCLE THERAPEUTICS PLC净利率更高（-42.0% vs -438.1%，领先396.1%），BICYCLE THERAPEUTICS PLC同比增速更快（1193.3% vs 220.4%），过去两年Dominari Holdings Inc.的营收复合增速更高（369.1% vs 56.7%）
Bicycle Therapeutics是一家临床阶段生物制药企业，专注于开发双环肽类创新疗法以解决未被满足的医疗需求，核心管线覆盖肿瘤、罕见病与免疫疾病领域，在欧美布局运营，与全球头部药企达成战略合作推进候选药物落地。
BCYC vs DOMH — 直观对比
营收规模更大
BCYC
是对方的1.6倍
$30.1M
营收增速更快
BCYC
高出972.9%
220.4%
净利率更高
BCYC
高出396.1%
-438.1%
两年增速更快
DOMH
近两年复合增速
56.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $48.0M | $30.1M |
| 净利润 | $-20.2M | $-131.8M |
| 毛利率 | — | — |
| 营业利润率 | -51.5% | -8.9% |
| 净利率 | -42.0% | -438.1% |
| 营收同比 | 1193.3% | 220.4% |
| 净利润同比 | 61.1% | -12426.2% |
| 每股收益（稀释后） | $-0.29 | $-6.94 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCYCDOMH
| Q4 25 | $48.0M | $30.1M | ||
| Q3 25 | $11.7M | $50.8M | ||
| Q2 25 | $2.9M | $34.1M | ||
| Q1 25 | $10.0M | $8.1M | ||
| Q4 24 | $3.7M | $9.4M | ||
| Q3 24 | $2.7M | $4.0M | ||
| Q2 24 | $9.4M | $6.2M | ||
| Q1 24 | $19.5M | $1.4M |
净利润BCYCDOMH
| Q4 25 | $-20.2M | $-131.8M | ||
| Q3 25 | $-59.1M | $125.2M | ||
| Q2 25 | $-79.0M | $16.6M | ||
| Q1 25 | $-60.8M | $-32.5M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-50.8M | $-4.2M | ||
| Q2 24 | $-39.8M | $-6.1M | ||
| Q1 24 | $-26.6M | $-5.4M |
营业利润率BCYCDOMH
| Q4 25 | -51.5% | -8.9% | ||
| Q3 25 | -558.6% | -3.1% | ||
| Q2 25 | -2965.8% | -57.0% | ||
| Q1 25 | -703.7% | -394.6% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | -2385.9% | -79.1% | ||
| Q2 24 | -498.3% | -44.3% | ||
| Q1 24 | -162.4% | -205.2% |
净利率BCYCDOMH
| Q4 25 | -42.0% | -438.1% | ||
| Q3 25 | -503.7% | 246.4% | ||
| Q2 25 | -2703.8% | 48.7% | ||
| Q1 25 | -608.9% | -400.5% | ||
| Q4 24 | — | 11.4% | ||
| Q3 24 | -1898.4% | -104.2% | ||
| Q2 24 | -425.3% | -99.1% | ||
| Q1 24 | -136.0% | -398.0% |
每股收益（稀释后）BCYCDOMH
| Q4 25 | $-0.29 | $-6.94 | ||
| Q3 25 | $-0.85 | $7.27 | ||
| Q2 25 | $-1.14 | $1.12 | ||
| Q1 25 | $-0.88 | $-3.02 | ||
| Q4 24 | — | $0.21 | ||
| Q3 24 | $-0.74 | $-0.67 | ||
| Q2 24 | $-0.77 | $-1.01 | ||
| Q1 24 | $-0.62 | $-0.91 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $628.1M | $80.5M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $610.0M | $69.4M |
| 总资产 | $717.6M | $112.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BCYCDOMH
| Q4 25 | $628.1M | $80.5M | ||
| Q3 25 | $648.3M | $176.2M | ||
| Q2 25 | $721.5M | $28.2M | ||
| Q1 25 | $793.0M | $18.9M | ||
| Q4 24 | $879.5M | $8.2M | ||
| Q3 24 | $890.9M | $7.2M | ||
| Q2 24 | $961.4M | $12.1M | ||
| Q1 24 | $457.0M | $7.1M |
总债务BCYCDOMH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $30.9M | — | ||
| Q1 24 | $30.8M | — |
股东权益BCYCDOMH
| Q4 25 | $610.0M | $69.4M | ||
| Q3 25 | $618.5M | $210.2M | ||
| Q2 25 | $668.9M | $88.6M | ||
| Q1 25 | $740.3M | $42.4M | ||
| Q4 24 | $793.1M | $39.9M | ||
| Q3 24 | $831.0M | $38.3M | ||
| Q2 24 | $873.8M | $42.4M | ||
| Q1 24 | $356.0M | $47.7M |
总资产BCYCDOMH
| Q4 25 | $717.6M | $112.9M | ||
| Q3 25 | $764.0M | $223.4M | ||
| Q2 25 | $832.2M | $109.3M | ||
| Q1 25 | $883.9M | $52.3M | ||
| Q4 24 | $956.9M | $47.1M | ||
| Q3 24 | $996.7M | $43.4M | ||
| Q2 24 | $1.1B | $49.1M | ||
| Q1 24 | $547.1M | $52.2M |
负债/权益比BCYCDOMH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.04× | — | ||
| Q1 24 | 0.09× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.3M | $22.7M |
| 自由现金流经营现金流 - 资本支出 | $-19.9M | — |
| 自由现金流率自由现金流/营收 | -41.5% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-252.0M | — |
8季度趋势，按日历期对齐
经营现金流BCYCDOMH
| Q4 25 | $-19.3M | $22.7M | ||
| Q3 25 | $-71.2M | $-4.9M | ||
| Q2 25 | $-72.8M | $-353.0K | ||
| Q1 25 | $-86.4M | $1.2M | ||
| Q4 24 | $-164.7M | $-16.7M | ||
| Q3 24 | $-39.8M | $-4.7M | ||
| Q2 24 | $-44.6M | $1.4M | ||
| Q1 24 | $-70.9M | $-8.6M |
自由现金流BCYCDOMH
| Q4 25 | $-19.9M | — | ||
| Q3 25 | $-71.8M | — | ||
| Q2 25 | $-73.3M | — | ||
| Q1 25 | $-87.0M | — | ||
| Q4 24 | $-166.0M | — | ||
| Q3 24 | $-40.3M | — | ||
| Q2 24 | $-45.0M | — | ||
| Q1 24 | $-70.9M | — |
自由现金流率BCYCDOMH
| Q4 25 | -41.5% | — | ||
| Q3 25 | -612.3% | — | ||
| Q2 25 | -2509.7% | — | ||
| Q1 25 | -871.7% | — | ||
| Q4 24 | -4475.7% | — | ||
| Q3 24 | -1504.7% | — | ||
| Q2 24 | -481.2% | — | ||
| Q1 24 | -362.9% | — |
资本支出强度BCYCDOMH
| Q4 25 | 1.2% | — | ||
| Q3 25 | 5.7% | — | ||
| Q2 25 | 17.1% | — | ||
| Q1 25 | 6.1% | — | ||
| Q4 24 | 33.3% | — | ||
| Q3 24 | 16.3% | — | ||
| Q2 24 | 4.5% | — | ||
| Q1 24 | 0.1% | — |
现金转化率BCYCDOMH
| Q4 25 | — | — | ||
| Q3 25 | — | -0.04× | ||
| Q2 25 | — | -0.02× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.65× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCYC
暂无分部数据
DOMH
| Chief Operating Decision Maker | $30.1M | 100% |
| Commissions | $458.0K | 2% |
